Waters SELECT SERIES MRT mass spectrometer

Significance of the Topic

The integration of ultra-high resolution and parts-per-billion mass accuracy into time-of-flight (TOF) mass spectrometry addresses critical challenges in small molecule analysis, biopharmaceutical characterization and molecular imaging. By delivering consistent performance independent of scan speed, this approach enhances confidence in compound identification and spatial mapping in complex biological matrices.

Study Objectives and Overview

This whitepaper introduces the SELECT SERIES MRT platform, built around a Multi-Reflecting TOF mass analyzer, and demonstrates its capabilities for:

• High-resolution UPLC-MS/MS workflows with ppb mass accuracy
• Advanced MALDI and DESI mass spectrometry imaging at cellular scales
• Enhanced biologics characterization through precise isotope resolution

Methodology and Instrumentation

The system employs a gridless Multi-Reflecting TOF analyzer coupled to a state-of-the-art quadrupole and high-performance ion sources:

• UPLC separated analytes introduced via an electrospray ionization interface with lockmass calibration for routine ppb mass precision
• MALDI source optimized for 10 μm–20 μm spatial resolution imaging
• DESI XS sprayer featuring heated transfer lines for enhanced sensitivity and molecular range
• Resolution Enhancement Mode (REM) focusing the TOF duty cycle to exceed 300 000 FWHM for targeted m/z windows

Key Results and Discussion

Performance benchmarks highlight:

• Uncompromised mass resolution at high scan rates (2 Hz to 30 Hz), resolving isomeric glucuronides in LC-MSE experiments
• Routine sub-ppm mass accuracy for intact small molecules (e.g., marbofloxacin) and high fidelity isotope structure in both MS and MS/MS spectra
• Clear separation of native vs deamidated peptide variants and fully resolved antibody subunit isotopic envelopes, enabling accurate monoisotopic mass assignments
• High-definition MALDI imaging at 10 μm pixel size and DESI imaging with full-spectrum molecular coverage in reduced acquisition times

Benefits and Practical Applications

The SELECT SERIES MRT platform offers:

• Unambiguous identification of trace analytes in complex matrices for pharmaceutical and environmental analysis
• Accelerated decision-making in biopharma development via precise peptide mapping and post-translational modification profiling
• Enhanced imaging clarity and throughput for tissue distribution studies in biomarker discovery and pathology

Future Trends and Applications

Emerging directions include integration with advanced informatics and machine learning for automated feature annotation, expansion into single-cell and subcellular imaging, and coupling with novel front-end separations (e.g., ion mobility) to further elevate specificity and throughput.

Conclusion

The SELECT SERIES MRT redefines TOF mass spectrometry by merging exceptional mass resolution, fast acquisition and versatile source interchangeability. Its ability to maintain ppb mass accuracy and resolve fine isotope details at high speeds empowers laboratories across small molecule quantitation, biologics characterization and multi-modal imaging to achieve unprecedented analytical confidence.